Refine by
Drug Identification Articles & Analysis
26 news found
As an antiviral preclinical contract research organization, Creative Diagnostics has enhanced its ability to provide a full range of services from target identification and validation, lead generation & optimization, to preclinical development support to meet the growing global demand for rapid and reliable antiviral drug discovery. Target ...
The platform developed by Protheragen-ING AI-Pharma is a revolutionary step forward in the identification and optimization of drug candidates. The traditional process of drug discovery is notoriously lengthy and resource-intensive, often requiring extensive experimental trials and significant manual analysis. ...
One of the key methodologies employed by CD ComputaBio is forward screening, which involves the identification of potential compounds based on known targets. This process is divided into virtual screening based on molecular docking and virtual screening based on pharmacophore, allowing for the efficient identification of promising drug ...
Beyond academic research and transplantation applications, CD Genomics' HLA typing solutions hold great promise in pharmaceutical drug development. They facilitate the identification of patient cohorts with specific HLA alleles, essential for developing targeted therapies. ...
Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with the aim of providing efficient and reliable solutions for the pharmaceutical industry's drug development endeavors. ...
Meanwhile, the new services are expected to help pharmaceutical companies develop safe and effective drugs more quickly and efficiently, ultimately benefiting patients and improving outcomes. ...
Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. The company has optimized its Cancer Hotspot Panel Sequencing service to meet the most ...
One of the most significant post-translational modifications during protein characterization is glycosylation. It affects the drug's biological activity, serum half-life, stability, and immunogenicity, which alters how the drug interacts with the patient's cells. ...
The application of LC-MS/MS in biotechnological drug metabolite identification is a popular research topic. Meanwhile, high resolution mass spectrometry (HRMS) has gained increasing attention in recent years as a complete protein quantification strategy due to its ability to directly determine the content of protein drugs and metabolites. ...
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across a range of therapeutic and biological target classes today announced a collaboration agreement in AI for new drug design. ...
ByIktos
Various new services are included in this release, such as GPCR Target Identification, GPCR Target Validation, GPCR Ligand Identification, GPCR Drug Design, and Anti-GPCR Antibody Discovery. On example is the GPCR Target Identification service. Target identification is the cornerstone of successful ...
Under the agreement, Iktos generative modelling technology will be implemented and applied to several Teijin Pharma’s small molecule drug discovery projects to expedite the identification of potential pre-clinical candidates. ...
ByIktos
Under the agreement, Iktos will apply its de novo ligand and structure-based generative modelling technologies and software Makya™, its AI-based retrosynthesis analysis and planning tool Spaya™, and know-how complementing Ono’s drug discovery capabilities to expedite the identification of potential pre-clinical candidates and to identify ...
ByIktos
Creative Biostructure Drug Discovery, a sub-brand of Creative Biostructure, established to apply its expertise in structural biology and membrane proteins to drug discovery process, now offers natural product identification and production service for drug discovery from natural products. ...
Transcriptomics enables genome-wide analysis of transcription at single-nucleotide resolution, including determination of the relative abundance of transcripts, unbiased identification of alternative splicing events and post-transcriptional RNA editing events, and detection of single nucleotide polymorphisms (SNPs). ...
Combines Exscientia’s leading AI-driven drug identification and design capabilities with GT Apeiron’s expertise in cyclin-dependent kinase (CDK) targets for oncology. Expands existing CDK7 drug discovery partnership with additional CDK targeting drugs Oxford & Shanghai – July 21st, 2021 – Exscientia, ...
We believe Mentanine® can become a ‘life-changer,’ improving quality of life for many and without the side effects caused by larger CBD doses,” he emphasized. Regulatory Pathway and Drug Identification Number (DIN) There is strong evidence from preclinical trial results that CanaQuest’s modified formulation, in combination with its ...
Therefore, it plays a key role in improving the pharmacokinetics and pharmacodynamic properties of protein drugs. Therefore, the identification of PEGylated proteins is a key step in biotechnology drug quality control and pharmacokinetic research. Creative Proteomics has diversified PEGylated protein analysis technologies, which can solve ...
CanaQuest has identified the regulatory pathways to obtain Drug Identification Numbers (DINs) for its two Master Formations, Mentanine®Rx, and Mentabinol®Rx, in Canada and the USA. ...
CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma, United Kingdom, a ...